|

Succimer Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Chemet, DMSA, Meso 2, 3-Dimercaptosuccinic Acid

Pipeline

Phase 1: 1

Top Sponsors

  • M.D. Anderson Cancer Center1

Indications

  • Very High Risk Myelodysplastic Syndrome1
  • Secondary Myelodysplastic Syndrome1
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive1
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome1
  • Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive1

Houston, Texas1 trial

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

M D Anderson Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.